Construction of multi-target-point-based hypoglycemic evaluation system and application of multi-target-point-based hypoglycemic evaluation system in formula optimization
The invention discloses construction based on a multi-target hypoglycemic evaluation system and application of the multi-target hypoglycemic evaluation system in formula optimization, which is characterized in that the multi-target hypoglycemic evaluation system is established for the first time by...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
08.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention discloses construction based on a multi-target hypoglycemic evaluation system and application of the multi-target hypoglycemic evaluation system in formula optimization, which is characterized in that the multi-target hypoglycemic evaluation system is established for the first time by using respectively constructed high-throughput screening models of alpha-amylase, alpha-glucosidase, dipeptidyl kinin IV and protein tyrosine phosphatase 1B inhibitors; the method is more comprehensive, efficient and convenient in screening of active raw materials for reducing blood sugar and optimization of a formula. The composition of the formula is disassembled and optimized from activity comparison of different action targets according to formula optimization, and the hypoglycemic activity and application universality of the formula under multiple targets can be effectively improved.
本发明公开了一种基于多靶点降血糖评价体系构建及其在组方优化中的应用,其首次将分别构建的α-淀粉酶、α-葡萄糖苷酶、二肽激肽酶Ⅳ、蛋白酪氨酸磷酸酶1B抑制剂高通量筛选模型建立多靶点降血糖评价体系,在降血糖活性原料筛选和组方优化中更加全面、高效、便捷。针对组方 |
---|---|
AbstractList | The invention discloses construction based on a multi-target hypoglycemic evaluation system and application of the multi-target hypoglycemic evaluation system in formula optimization, which is characterized in that the multi-target hypoglycemic evaluation system is established for the first time by using respectively constructed high-throughput screening models of alpha-amylase, alpha-glucosidase, dipeptidyl kinin IV and protein tyrosine phosphatase 1B inhibitors; the method is more comprehensive, efficient and convenient in screening of active raw materials for reducing blood sugar and optimization of a formula. The composition of the formula is disassembled and optimized from activity comparison of different action targets according to formula optimization, and the hypoglycemic activity and application universality of the formula under multiple targets can be effectively improved.
本发明公开了一种基于多靶点降血糖评价体系构建及其在组方优化中的应用,其首次将分别构建的α-淀粉酶、α-葡萄糖苷酶、二肽激肽酶Ⅳ、蛋白酪氨酸磷酸酶1B抑制剂高通量筛选模型建立多靶点降血糖评价体系,在降血糖活性原料筛选和组方优化中更加全面、高效、便捷。针对组方 |
Author | TANG WAN WANG SUQIN WANG ZHE XU JIAN LAI FULI LI WEIQIN CUI LINGMIN |
Author_xml | – fullname: XU JIAN – fullname: CUI LINGMIN – fullname: TANG WAN – fullname: LAI FULI – fullname: LI WEIQIN – fullname: WANG SUQIN – fullname: WANG ZHE |
BookMark | eNqljE0KwjAQRrPQhX93iAcIWIoVl1IUV67clzGd1kAyE5qpUI_kKZXiAQRX3-K9983VhJhwpl4lU5Kut-KYNDc69F6cEehaFBPZkZgbJKz1fYjc-sFicFbjA3wPY5OGJBg0UK0hRu8s_HvlSDfcfWrQHMUF9xzxUk0b8AlX312o9el4Lc8GI1eYIlgklKq8ZNmuKDbbfX7If3HeYChdQw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 一种基于多靶点降血糖评价体系构建及其在组方优化中的应用 |
ExternalDocumentID | CN117660593A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN117660593A3 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 09 05:00:27 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN117660593A3 |
Notes | Application Number: CN202311629456 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240308&DB=EPODOC&CC=CN&NR=117660593A |
ParticipantIDs | epo_espacenet_CN117660593A |
PublicationCentury | 2000 |
PublicationDate | 20240308 |
PublicationDateYYYYMMDD | 2024-03-08 |
PublicationDate_xml | – month: 03 year: 2024 text: 20240308 day: 08 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | JING BRAND CO., LTD |
RelatedCompanies_xml | – name: JING BRAND CO., LTD |
Score | 3.6632683 |
Snippet | The invention discloses construction based on a multi-target hypoglycemic evaluation system and application of the multi-target hypoglycemic evaluation system... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
Title | Construction of multi-target-point-based hypoglycemic evaluation system and application of multi-target-point-based hypoglycemic evaluation system in formula optimization |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240308&DB=EPODOC&locale=&CC=CN&NR=117660593A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NS8NAEB1qFfWmVdH6wQqS26LWpM0liN2kFKFpkSq9lU22aSs1CTQi9Sf5K53ZpqYXvXhbsjCQGd7O7M7MG4CrSFqhpSKTB6a08YISSi4jqXgtbAQYcNQQY5TR7fj19rP5OLAGJXhd9cJontAPTY6IiAoR75k-r9PiEcvVtZXz62CKn5L7Vt9xjfx2TORyN7bhNh2v13W7whDCEb7hPzm3RIRI4-seNmCTwmji2fdemtSVkq67lNYebPVQWpztQ-lzUoEdsZq8VoHtTp7wxmWOvfkBfNFszRXbK0sipmsB-bKUm6fJNM44-STFJos0Gc8WIdW9s4LOmy1Zm5mMFVvLW_9H1DRmFPS-zyRL8Ox5y5s6D-Gy5fVFm-NPD380PBR-oZ-7IyjHSTw6BiYtJSUa0xzVpIkrSV2oiPp6pKSy640TqP4up_rX5inskrV0MZd9BmXU3ugcvXsWXGizfANX2LGJ |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT8JAEJ0gGvGmqFH8WhPT20bFFnppjGwhqFCIQeONTLtUMNg2ocbgT_JXOrsU4aIXb5tuMkln8nZ2dmbeAJyFaAWWDE3um2hTgBIgxxAlLwdVny4cZcKYyui2vUrz0bx7tp5z8DrvhdE8oR-aHJEQFRDeU31eJ4tHLFfXVk7O_RF9iq8bPcc1suhYkctd2IZbc-rdjtsRhhCO8AzvwblURIhqfN3NCqxWKSTUodJTTXWlJMsupbEJa12SFqVbkPscFqEg5pPXirDezhLetMywN9mGLzVbc872yuKQ6VpAPivl5kk8ilKufJJkw2kSv4yngap7Zws6bzZjbWYYSbaUt_6PqFHE1KX3fYwsprPnLWvq3IHTRr0nmpx-uv-j4b7wFvq52oV8FEeDPWBoSUQypjkoo0krVF2ohPpKKFHaleo-lH6XU_pr8wQKzV671W_devcHsKEspwu77EPIkyYHR-TpU_9Ym-gby3S0cw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Construction+of+multi-target-point-based+hypoglycemic+evaluation+system+and+application+of+multi-target-point-based+hypoglycemic+evaluation+system+in+formula+optimization&rft.inventor=XU+JIAN&rft.inventor=CUI+LINGMIN&rft.inventor=TANG+WAN&rft.inventor=LAI+FULI&rft.inventor=LI+WEIQIN&rft.inventor=WANG+SUQIN&rft.inventor=WANG+ZHE&rft.date=2024-03-08&rft.externalDBID=A&rft.externalDocID=CN117660593A |